Table I.
Clinical data and pharmacotherapy of the study group (n = 57) – data presented as mean value with standard deviation (SD) or percentage of patients (%)
| Parameter | Results |
|---|---|
| Age [years] | 66.35 ±8.69 |
| Body mass index (BMI) [kg/m2] | 25.82 ±4.15 |
| Male gender, n (%) | 54 (94.7) |
| History of myocardial infarction (%) | 64.9 |
| Diabetes (%) | 40.4 |
| Hypertension (%) | 63.2 |
| Chronic obstructive pulmonary disease (%) | 19.3 |
| Hypercholesterolemia (%) | 77.2 |
| Paroxysmal atrial fibrillation (%) | 22.8 |
| Permanent atrial fibrillation (%) | 17.5 |
| Left bundle branch block (%) | 66.6 |
| Anemia (%) | 3.5 |
| Smoking (%) | 22.8 |
| Chronic kidney disease (%) | 31.6 |
| Ischemic background of heart failure (%) | 71.9 |
| History of coronary artery bypass graft (CABG) (%) | 14.0 |
| History of percutaneous coronary intervention (PCI) (%) | 17.5 |
| B-blockers (%) | 96.5 |
| Angiotensin converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARB) (%) | 86.0 |
| Loop diuretics (%) | 87.8 |
| Digoxin (%) | 22.8 |
| Amiodarone (%) | 31.6 |